GlassScriptPhysician profile
Jay Y Chun
NPI 1548227663
$20,099.52
in general payments reported to CMS, 2019-2025
17 companies · $756 in 2025
The $756 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,940 · 2021: $69.75 · 2022: $8,079 · 2023: $4,365 · 2024: $891 · 2025: $756.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,800 · Food and Beverage: $1,697 · Travel and Lodging: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,800.00 |
| Food and Beverage | $1,697.34 |
| Travel and Lodging | $513.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $5,762.00 | 2019 | |
| Alphatec Spine, INC | $5,361.55 | 2021-2023 | Solus Alif |
| Ucb, INC. | $3,800.00 | 2023 | Bimzelx |
| Globus Medical, INC. | $1,659.03 | 2022-2023 | Excelsiusgps Robotic Navigation System |
| Scilex Pharmaceuticals INC. | $1,413.28 | 2021-2022 | |
| Medtronic, INC. | $1,033.54 | 2024-2025 | Mazor X System, Atlantis Anterior Cervical Plate System, Medtronic Reusable Instruments |
| Providence Medical Technology, INC. | $295.87 | 2022-2024 | |
| Stryker Corporation | $177.96 | 2019 | |
| Nevro Corp. | $141.39 | 2024 | Senza |
| Highridge Medical LLC | $128.66 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Ebi, LLC | $128.66 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
| Boston Scientific Corporation | $103.40 | 2021-2025 | General - Pain Management |
| Sanara Medtech INC. | $26.61 | 2025 | Celleraterx |
| Abbott Laboratories | $23.77 | 2021 | |
| Zimvie INC. | $23.07 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $20.73 | 2024 | Prevena |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Chun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.